Image: Profile picture of Mathis Korseberg Stokke

Mathis Korseberg Stokke

Group Leader, Associate Professor & Senior Consultant

Stokke group

2020 Specialist in Cardiology
2011 PhD Cellular electrophysiology, IEMR
2005 MD University of Copenhagen, Denmark

2020- Associate Professor, IEMR
2020- Consultant Cardiologist, Arrhythmia Unit, Dept. of Cardiology, Oslo University Hospital Rikshospitalet
2013- Deputy Director of NORHEART (Norwegian PhD School of Heart Research)
2018-2019 Head of Center for Heart Failure Research

– University of Oslo (Equipment)
– South-Eastern Norway Regional Health Authority (3 PhD students)
– Fougner Hartmann Familiefond (Equipment)
– Rakel and Otto Bruuns Legat (Running costs)

Awards, committees and memberships
– Fellow of the European Society of Cardiology
– Member of the European Working Group for Cardiac Cellular Electrophysiology
– Member of Organizing Committee Annual CHFR Research Symposium 2007-2019

Collaborations outside IEMR
– Prof. Mark E. Anderson, Johns Hopkins University School of Medicine, Baltimore, USA
– Prof. Stephan E. Lehnart, University of Göttingen, Germany
– Prof. Thor Edvardsen and Ass. Prof. Kristina Haugaa, Dept. of Cardiology, Oslo University Hospital Rikshospitalet
– Prof. Mark Boyett and Senior lecturer Halina Dobrzynski, University of Manchester
– Prof. David Eisner and Prof. Andrew W. Trafford, Unit of Cardiac Physiology, University of Manchester, UK.

Research area

  • Arrhythmias
  • Cardiomyopathies
  • Clinical research
  • Electrophysiology
  • Excercise physiology
  • Excitation contraction coupling
  • Genetic cardiology
  • Ischemic heart disease

Latest publications

view all >
Sadredini M, Manotheepan R, Lehnart SE, Anderson ME, Sjaastad I, Stokke MK (2021)
The oxidation-resistant CaMKII-MM281/282VV mutation does not prevent arrhythmias in CPVT1
Physiol Rep, 9 (18), e15030
PubMed 34558218 DOI 10.14814/phy2.15030
Sadredini M, Haugsten Hansen M, Frisk M, Louch WE, Lehnart SE, Sjaastad I, Stokke MK (2021)
CaMKII inhibition has dual effects on spontaneous Ca2+ release and Ca2+ alternans in ventricular cardiomyocytes from mice with a gain-of-function RyR2 mutation
Am J Physiol Heart Circ Physiol, 321 (2), H446-H460
PubMed 34270372 DOI 10.1152/ajpheart.00011.2021
Berger SG, Sjaastad I, Stokke MK (2021)
Right ventricular involvement in hypertrophic cardiomyopathy: evidence and implications from current literature
Scand Cardiovasc J, 55 (4), 195-204
PubMed 33759664 DOI 10.1080/14017431.2021.1901979
Danielsen TK, Sadredini M, Manotheepan R, Aronsen JM, Frisk M, Hansen MH, Andressen KW, Hougen K, Levy FO, Louch WE, Sejersted OM, Sjaastad I, Stokke MK (2021)
Exercise Training Stabilizes RyR2-Dependent Ca2+ Release in Post-infarction Heart Failure
Front Cardiovasc Med, 7, 623922
PubMed 33569394 DOI 10.3389/fcvm.2020.623922
Skogestad J, Aronsen JM, Tovsrud N, Wanichawan P, Hougen K, Stokke MK, Carlson CR, Sjaastad I, Sejersted OM, Swift F (2020)
Coupling of the Na+/K+-ATPase to Ankyrin B controls Na+/Ca2+ exchanger activity in cardiomyocytes
Cardiovasc Res, 116 (1), 78-90
PubMed 30949686 DOI 10.1093/cvr/cvz087
view all >